Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.biospace.com/article/motif-bio-confirms-receipt-of-fda-meeting-minutes/?s=95

BIOSPACE
15 Oct 2019

https://endpts.com/the-fda-is-forcing-a-small-antibiotic-player-back-to-the-clinic-for-a-new-trial-10-years-after-it-was-first-rejected/

John Carroll ENDPTS
06 Jun 2019

https://globenewswire.com/news-release/2019/02/14/1725149/0/en/Motif-Bio-Receives-Complete-Response-Letter-from-the-FDA.html

GLOBENEWSWIRE
13 Feb 2019

https://www.nasdaq.com/press-release/motif-bio-announces-notice-of-allowance-for-two-us-iclaprim-patents-with-expiration-in-2037-20180808-00060

NASDAQ
08 Aug 2018

https://www.directorstalkinterviews.com/motif-bio-announces-notice-of-allowance-for-two-u-s-iclaprim-patents-with-expiration-in-2037/412756417

DIRECTORSTALK INTERVIEW
07 Aug 2018
Motif Bio Submits NDA for Iclaprim
Motif Bio Submits NDA for Iclaprim

14 Jun 2018

// GLOBENEWSWIRE

https://globenewswire.com/news-release/2018/06/14/1524355/0/en/Motif-Bio-Submits-NDA-for-Iclaprim.html

GLOBENEWSWIRE
14 Jun 2018